- Telehealth Visits
- Insurance plan information
Ginger Cupit, DO
Family Medicine • Women's Health- Telehealth Visits
- Insurance plan information
Ginger Cupit, DO
Family Medicine • Women's Health- Telehealth Visits
- Insurance plan information
On this page
Education & training
Board certification
- Sports Medicine, American Board of Family Medicine
- Family Practice, American Board of Family Medicine
Fellowship
- Sports Medicine, UCSF School of Medicine -GME
Residency
- Family Medicine, Georgetown Univ/Providence Hospital FP Residency
Internship
- Family Medicine, Georgetown Univ/Providence Hospital FP Residency
Degree
- DO, Oregon Health Sciences University - Ashland
My expertise
Specialties
- Family Medicine
- Women's Health
Locations
Clinical Trials query: q=health_gateway_id_ss%3A%28%223574%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=start_date_dt+asc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%223574%22%29&rows=4&sort=date_published+asc&fq=content_type%3A%22Publication%22
Showing 1-6 of 158 reviews
- May 28, 20265 out of 5 Stars
Dr Cupit spent considerable time with me during this appointment and was able to address all of my concerns
- May 14, 20265 out of 5 Stars
Dr.Cupit listened and addressed by worries and concerns
- May 7, 20265 out of 5 Stars
My experience over past two years has been so good that my mother and sister are going to switch to doctors in this practice.
- May 5, 20265 out of 5 Stars
Excellent!
- April 18, 20265 out of 5 Stars
Dr. Cupit listened carefully, provided clear explanations and included me in decisions regarding my care.
- April 7, 20265 out of 5 Stars
Dr. Ginger Cupit is excellent!
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.
The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.